DNA Vaccines (Hepatitis)
"New Approaches to Passive and Active Immunoprophylaxis."
Published in Gene Therapy Weekly, May 31st, 1999
NIH Grant Number: 1Z01AI00823-01. Principle Investigator: R. Purcell. Description: "Vaccines remain one of the most cost-beneficial medical interventions. The Hepatitis Virus Section (HVS) has been instrumental in the development of licensed vaccines for the prevention of hepatitis A and hepatitis B. When appropriately administered as part of an integrated public health program, they can have a very large impact on the incidence of these two diseases worldwide. Other hepatitis viruses have worldwide importance as pathogens. Among these are hepatitis C virus and hepatitis E virus (HEV). The HVS has developed a candidate hepatitis E vaccine that is highly...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (1999-05-31)
More Articles from Gene Therapy Weekly
- Conference Coverage (ASCO)
Retroviral Vector Safe When Given As Multiple Injections - Conference Coverage (ASCO)
Liposomes Increase Immune Response in Cancer Vaccine - Pathogenesis
Neurodegeneration Precedes Plaque Formation - Colorectal Cancer (ASCO Conference News)
Tumor Characteristics May Help Explain Tumor Biology and Prognosis - Drug Development
Controlling Telomerase Gene Opens Way for Cancer Drugs - Genetics
Gene Controlling Hippocampus Development Discovered - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
